Amgen, UCB bone loss experiment set to fly on last US Space Shuttle
This article was originally published in Scrip
Executive Summary
If the weather holds out, on 8 July, UCB's and Amgen's preclinical bone loss antibody will make history being tested as one of the last experiments on a US Space Shuttle when Atlantis blasts off into space as the final shuttle mission ever to fly.